Skip to Content

2,712 Results Found

  • Review
  • Open Access
79 Citations
16,494 Views
19 Pages

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders

  • Yazan S. Batarseh,
  • Quoc-Viet Duong,
  • Youssef M. Mousa,
  • Sweilem B. Al Rihani and ,
  • Khaled Elfakhri and
  • Amal Kaddoumi
  • + 1 author+ 0 author

Amyloid-β (Aβ) pathology is known to promote chronic inflammatory responses in the brain. It was thought previously that Aβ is only associated with Alzheimer’s disease and Down syndrome. However, studies have shown its involvement in many other neuro...

(This article belongs to the Special Issue Amyloid-beta and Neurological Diseases)
  • Article
  • Open Access
16 Citations
5,915 Views
22 Pages

EDEM1 Regulates Amyloid Precursor Protein (APP) Metabolism and Amyloid-β Production

  • Jowita Nowakowska-Gołacka,
  • Justyna Czapiewska,
  • Hanna Sominka,
  • Natalia Sowa-Rogozińska and
  • Monika Słomińska-Wojewódzka

23 December 2021

Endoplasmic reticulum (ER) degradation-enhancing α-mannosidase-like protein 1 (EDEM1) is a quality control factor directly involved in the endoplasmic reticulum-associated degradation (ERAD) process. It recognizes terminally misfolded proteins...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
40 Citations
5,410 Views
14 Pages

Interactions of Amyloid-β with Membrane Proteins

  • Benita Wiatrak,
  • Janusz Piasny,
  • Amadeusz Kuźniarski and
  • Kazimierz Gąsiorowski

In developing and developed countries, an increasing elderly population is observed. This affects the growing percentage of people struggling with neurodegenerative diseases, including Alzheimer’s disease. Nevertheless, the pathomechanism of this dis...

(This article belongs to the Special Issue Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases 2.0)
  • Review
  • Open Access
13 Citations
3,478 Views
10 Pages

26 July 2022

Protein folding is the most fundamental and universal example of biomolecular self-organization and is characterized as an intramolecular process. In contrast, amyloidogenic proteins can interact with one another, leading to protein aggregation. The...

(This article belongs to the Special Issue Frontiers in Protein Folding and Related Areas – in Memory of Professor Sir Christopher M. Dobson (1949–2019))
  • Review
  • Open Access
20 Citations
5,233 Views
25 Pages

Therapeutic Advances in Targeting the Amyloid-β Pathway for Alzheimer’s Disease

  • Beiyu Zhang,
  • Yunan Li,
  • Huan Li,
  • Xinai Shen and
  • Zheying Zhu

13 October 2025

Alzheimer’s disease (AD) is the most common cause of dementia, characterized by progressive cognitive decline and neuropathological hallmarks, including amyloid-β (Aβ) plaques, neurofibrillary tangles (NFTs), and neurodegeneration. Si...

(This article belongs to the Section Neurodegenerative Diseases)
  • Article
  • Open Access
33 Citations
8,311 Views
20 Pages

The Effects of Endogenous Non-Peptide Molecule Isatin and Hydrogen Peroxide on Proteomic Profiling of Rat Brain Amyloid-β Binding Proteins: Relevance to Alzheimer’s Disease?

  • Alexei E. Medvedev,
  • Olga A. Buneeva,
  • Arthur T. Kopylov,
  • Oksana V. Gnedenko and ,
  • Marina V. Medvedeva,
  • Sergey A. Kozin,
  • Alexis S. Ivanov,
  • Victor G. Zgoda and
  • Alexander A. Makarov
  • + 4 authors+ 0 author

29 December 2014

The amyloid-β peptide is considered as a key player in the development and progression of Alzheimer’s disease (AD). Although good evidence exists that amyloid-β accumulates inside cells, intracellular brain amyloid-binding proteins remain poorly char...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
12 Citations
7,793 Views
13 Pages

Jowiseungchungtang Inhibits Amyloid-β Aggregation and Amyloid-β-Mediated Pathology in 5XFAD Mice

  • Soo Jung Shin,
  • Yu-on Jeong,
  • Seong Gak Jeon,
  • Sujin Kim and ,
  • Seong-kyung Lee,
  • Yunkwon Nam,
  • Yong Ho Park,
  • Dabi Kim,
  • Youn Seok Lee and
  • Minho Moon
  • + 8 authors+ 3 authors

13 December 2018

Alzheimer’s disease (AD) is a neurodegenerative disease, which is accompanied by memory loss and cognitive dysfunction. Although a number of trials to treat AD are in progress, there are no drugs available that inhibit the progression of AD. As...

(This article belongs to the Special Issue Nutrition and Aging)
  • Article
  • Open Access
14 Citations
6,774 Views
21 Pages

Interference with Amyloid-β Nucleation by Transient Ligand Interaction

  • Tao Zhang,
  • Jennifer Loschwitz,
  • Birgit Strodel,
  • Luitgard Nagel-Steger and
  • Dieter Willbold

Amyloid-β peptide (Aβ) is an intrinsically disordered protein (IDP) associated with Alzheimer’s disease. The structural flexibility and aggregation propensity of Aβ pose major challenges for elucidating the interaction between A&...

(This article belongs to the Special Issue Amyloid Inhibitors and Modulators)
  • Article
  • Open Access
697 Views
21 Pages

15 July 2026

Impaired amyloid-β clearance at the blood–brain barrier (BBB) contributes to Alzheimer’s disease (AD), yet the regulation of endothelial transport processes under neuroinflammatory conditions remains incompletely understood. Here, we...

  • Article
  • Open Access
9 Citations
2,388 Views
9 Pages

17 October 2022

Background: Elucidation of the mechanism of amyloid-β accumulation plays an important role in therapeutic strategies for Alzheimer’s disease (AD). The aim of this study is to elucidate the relationship between the function of the blood&nda...

(This article belongs to the Section Clinical Neurology)
  • Article
  • Open Access
9 Citations
2,883 Views
17 Pages

Amyloid-β Processing in Aged S100B Transgenic Mice Is Sex Dependent

  • Krista Minéia Wartchow,
  • Leticia Rodrigues,
  • Izabela Swierzy,
  • Michael Buchfelder and ,
  • Diogo Onofre de Souza,
  • Carlos-Alberto Gonçalves and
  • Andrea Kleindienst
  • + 2 authors+ 0 author

6 October 2021

(1) Background: Calcium-binding protein S100B is involved in neuroregeneration but has also been associated with neurodegeneration. These contrasting effects may result from concentration or duration of exposure. We investigated the effect of long-te...

(This article belongs to the Special Issue Neurobiology of Aging and Aging-Related Disorders)
  • Article
  • Open Access
19 Citations
3,871 Views
13 Pages

Effects of Curcumin and Ferulic Acid on the Folding of Amyloid-β Peptide

  • Evdokiya Salamanova,
  • Mariyana Atanasova,
  • Ivan Dimitrov and
  • Irini Doytchinova

The polyphenols curcumin (CU) and ferulic acid (FA) are able to inhibit the aggregation of amyloid-β (Aβ) peptide with different strengths. CU is a strong inhibitor while FA is a weaker one. In the present study, we examine the effects of CU and FA o...

(This article belongs to the Special Issue In Silico Activity Profiling of Natural Products)
  • Article
  • Open Access
6 Citations
4,018 Views
23 Pages

Vascular Heparan Sulfate and Amyloid-β in Alzheimer’s Disease Patients

  • Ilayda Ozsan McMillan,
  • Marla Gearing and
  • Lianchun Wang

Alzheimer’s disease (AD) is a debilitating neurodegenerative disease characterized by the accumulation of extracellular amyloid-β peptides (Aβ) within the cerebral parenchyma and vasculature, which is known as cerebral amyloid angiopa...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
178 Views
16 Pages

27 October 2026

Background/Objectives: Blood-based biomarkers may help prioritize patients for confirmatory amyloid testing. We compared amyloid positron emission tomography (PET) utilization and diagnostic yield between memory-clinic periods before and after plasma...

(This article belongs to the Section Neurodegenerative Diseases)
  • Article
  • Open Access
13 Citations
3,701 Views
15 Pages

Low-Dose Phosphodiesterase III Inhibitor Reduces the Vascular Amyloid Burden in Amyloid-β Protein Precursor Transgenic Mice

  • Yusuke Yakushiji,
  • Kazuhiro Kawamoto,
  • Kazuyoshi Uchihashi,
  • Masafumi Ihara and ,
  • Shigehisa Aoki,
  • Yukiko Nagaishi,
  • Kohei Suzuyama,
  • Yumiko Tsugitomi and
  • Hideo Hara
  • + 4 authors+ 0 author

A previous study reported that relatively high-dose cilostazol (0.3%) promoted the drainage of cerebrovascular amyloid-β (Aβ) protein in Aβ Precursor Protein (APP) transgenic mice overexpressing vasculotropic Aβ. We investigated w...

(This article belongs to the Special Issue Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases)
  • Review
  • Open Access
35 Citations
8,014 Views
14 Pages

13 February 2021

Aggregates of amyloid-β (Aβ) peptides are known to be related to Alzheimer’s disease. Their aggregation is enhanced at hydrophilic–hydrophobic interfaces, such as a cell membrane surface and air-water interface, and is inhibited by polyphenols, such...

(This article belongs to the Special Issue Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases 2.0)
  • Review
  • Open Access
28 Citations
8,448 Views
29 Pages

12 April 2022

Alzheimer’s disease is understood to be caused by amyloid fibrils and oligomers formed by aggregated amyloid-β (Aβ) peptides. This review article presents molecular dynamics (MD) simulation studies of Aβ peptides and Aβ frag...

(This article belongs to the Special Issue Frontiers in Protein Folding and Related Areas – in Memory of Professor Sir Christopher M. Dobson (1949–2019))
  • Article
  • Open Access
15 Citations
4,094 Views
13 Pages

29 January 2024

Alzheimer’s disease and Type 2 diabetes are two epidemiologically linked diseases which are closely associated with the misfolding and aggregation of amyloid proteins amyloid-β (Aβ) and human islet amyloid polypeptide (hIAPP), respect...

(This article belongs to the Section Molecular Biophysics)
  • Article
  • Open Access
39 Citations
6,084 Views
19 Pages

Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro

  • Nima Sasanian,
  • David Bernson,
  • Istvan Horvath,
  • Pernilla Wittung-Stafshede and
  • Elin K. Esbjörner

18 June 2020

Plaque deposits composed of amyloid-β (Aβ) fibrils are pathological hallmarks of Alzheimer’s disease (AD). Although copper ion dyshomeostasis is apparent in AD brains and copper ions are found co-deposited with Aβ peptides in pat...

(This article belongs to the Special Issue Toxic and Essential Metals in Human Health and Disease)
  • Opinion
  • Open Access
20 Citations
5,972 Views
9 Pages

10 February 2020

Alzheimer’s disease (AD) is characterized by deposition and accumulation of amyloid-β (Aβ) and its corresponding plaques within the brain. Although much debate exists whether these plaques are the cause or the effect of AD, the accumu...

(This article belongs to the Section Molecular and Cellular Neuroscience)
  • Review
  • Open Access
15 Citations
5,596 Views
16 Pages

Recent Research Progress in Fluorescent Probes for Detection of Amyloid-β In Vivo

  • Zhen-Yu Zhang,
  • Ze-Jun Li,
  • Ying-Hao Tang,
  • Liang Xu and ,
  • De-Teng Zhang,
  • Tian-Yi Qin and
  • Ya-Long Wang
  • + 2 authors+ 0 author

19 November 2023

Alzheimer’s disease (AD) is a neurodegenerative disease. Due to its complex pathological mechanism, its etiology is not yet clear. As one of the main pathological markers of AD, amyloid-β (Aβ) plays an important role in the developmen...

(This article belongs to the Special Issue Fluorescent Materials with Excellent Biocompatibility and Their Application in Bio-Sensing, Bio-Imaging (Volume II))
  • Article
  • Open Access
99 Citations
9,640 Views
21 Pages

Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-Degradation

  • Marcus O. W. Grimm,
  • Andrea Thiel,
  • Anna A. Lauer,
  • Jakob Winkler and ,
  • Johannes Lehmann,
  • Liesa Regner,
  • Christopher Nelke,
  • Daniel Janitschke,
  • Céline Benoist and
  • Tobias Hartmann
  • + 13 authors+ 8 authors

19 December 2017

Alzheimer’s disease (AD) is characterized by extracellular plaques in the brain, mainly consisting of amyloid-β (Aβ), as derived from sequential cleavage of the amyloid precursor protein. Epidemiological studies suggest a tight link between hypovitam...

(This article belongs to the Special Issue Vitamin D and Its Analogues: New Insights on Biological Effects and Therapeutic Uses)
  • Article
  • Open Access
18 Citations
5,667 Views
17 Pages

Ibuprofen Favors Binding of Amyloid-β Peptide to Its Depot, Serum Albumin

  • Ekaterina A. Litus,
  • Alexey S. Kazakov,
  • Evgenia I. Deryusheva,
  • Ekaterina L. Nemashkalova and ,
  • Marina P. Shevelyova,
  • Andrey V. Machulin,
  • Aliya A. Nazipova,
  • Maria E. Permyakova,
  • Vladimir N. Uversky and
  • Sergei E. Permyakov
  • + 5 authors+ 0 author

The deposition of amyloid-β peptide (Aβ) in the brain is a critical event in the progression of Alzheimer’s disease (AD). This Aβ deposition could be prevented by directed enhancement of Aβ binding to its natural depot, huma...

(This article belongs to the Special Issue Serum Albumin in Health and Disease: From Comparative Biochemistry to Translational Medicine)
  • Article
  • Open Access
24 Citations
3,563 Views
14 Pages

Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization

  • Massimiliano Cuccioloni,
  • Valentina Cecarini,
  • Laura Bonfili,
  • Riccardo Pettinari and ,
  • Alessia Tombesi,
  • Noemi Pagliaricci,
  • Laura Petetta,
  • Mauro Angeletti and
  • Anna Maria Eleuteri
  • + 4 authors+ 0 author

Alzheimer’s disease (AD) is a fatal neurodegenerative disorder associated with severe dementia, progressive cognitive decline, and irreversible memory loss. Although its etiopathogenesis is still unclear, the aggregation of amyloid-β (A&be...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
1 Citations
1,774 Views
10 Pages

Cerebral Amyloid-β Deposition, Axial Features, and Cognitive Alterations in Patients with Parkinson’s Disease Treated with Bilateral STN-DBS: A Long-Term Cohort Study

  • Francesco Cavallieri,
  • Alessandro Fraternali,
  • Annachiara Arnone,
  • Isabella Campanini and ,
  • Alessandro Marti,
  • Annalisa Gessani,
  • Valentina Fioravanti,
  • Maria Angela Molinari,
  • Giulia Di Rauso and
  • Franco Valzania
  • + 21 authors+ 16 authors

10 December 2024

Objectives: Our aim was to evaluate the possible long-term cerebral deposition of amyloid-β in patients with PD treated with subthalamic nucleus deep brain stimulation (STN-DBS) and its possible influence on axial and cognitive variables. Method...

(This article belongs to the Section Mechanisms of Diseases)
  • Article
  • Open Access
80 Citations
16,721 Views
24 Pages

23 April 2012

The Herb Rhinacanthus nasutus (L.) Kurz, which is native to Thailand and Southeast Asia, has become known for its antioxidant properties. Neuronal loss in a number of diseases including Alzheimer’s disease is thought to result, in part, from oxidativ...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
5 Citations
2,161 Views
12 Pages

The Detection of Toxic Amyloid-β Fibril Fragments Through a Surface Plasmon Resonance Immunoassay

  • Marten Beeg,
  • Beatrice Rocutto,
  • Elisabetta Battocchio,
  • Letizia Dacomo and ,
  • Alessandro Corbelli,
  • Fabio Fiordaliso,
  • Claudia Balducci and
  • Marco Gobbi
  • + 3 authors+ 0 author

4 December 2024

Amyloid-β1–42 (Aβ42) forms highly stable and insoluble fibrillar structures, representing the principal components of the amyloid plaques present in the brain of Alzheimer’s disease (AD) patients. The involvement of Aβ42 in...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
6 Citations
3,858 Views
19 Pages

Binding of Pro-Inflammatory Proteins S100A8 or S100A9 to Amyloid-β Peptide Suppresses Its Fibrillation

  • Ekaterina A. Litus,
  • Marina P. Shevelyova,
  • Alisa A. Vologzhannikova,
  • Evgenia I. Deryusheva and ,
  • Andrey V. Machulin,
  • Ekaterina L. Nemashkalova,
  • Maria E. Permyakova,
  • Andrey S. Sokolov,
  • Valeria D. Alikova and
  • Sergei E. Permyakov
  • + 6 authors+ 1 author

17 March 2025

Human serum albumin (HSA) is a natural depot of amyloid-β peptide (Aβ), a key player in Alzheimer’s disease (AD). HSA and pro-inflammatory Ca2+-binding proteins S100A8 and S100A9 are involved in Aβ metabolism and its deposition i...

  • Article
  • Open Access
94 Citations
8,914 Views
15 Pages

16 August 2017

Alzheimer′s disease (AD) is a fatal neurodegenerative disease. Brain amyloid-β deposition is a crucial feature of AD, causing neuronal cell death by inducing oxidative damage. Reactive oxygen species (ROS) activate NF-κB, which induces expression of...

  • Article
  • Open Access
13 Citations
8,142 Views
14 Pages

Aβ-40 Y10F Increases βfibrils Formation but Attenuates the Neurotoxicity of Amyloid-β Peptide

  • Xueling Dai,
  • Ping Chang,
  • Wenjuan Liu,
  • Ke Xu and ,
  • Yaxuan Sun,
  • Shigong Zhu and
  • Zhaofeng Jiang
  • + 2 authors+ 0 author

25 April 2012

Alzheimer’s disease (AD) is characterized by the abnormal aggregation of amyloid-β peptide (Aβ) in extracellular deposits known as senile plaques. The tyrosine residue (Tyr-10) is believed to be important in Aβ-induced neurotoxicity due to the format...

(This article belongs to the Special Issue Molecular Mechanisms of Organ-Specific Toxicity)
  • Article
  • Open Access
6 Citations
3,706 Views
10 Pages

Dietary Glycemic Load and Plasma Amyloid-β Biomarkers of Alzheimer’s Disease

  • Mélissa Gentreau,
  • Michel Raymond,
  • Cécilia Samieri,
  • Virginie Chuy and ,
  • Catherine Féart,
  • Claire Berticat and
  • Sylvaine Artero
  • + 2 authors+ 0 author

15 June 2022

Previous studies have highlighted links between a high-glycemic-load (GL) diet and Alzheimer’s disease in apolipoprotein E ε4 (APOE4) carriers. However, the impact of high-GL diet on plasma amyloid-β (Aβ), an Alzheimer’s...

(This article belongs to the Section Nutritional Epidemiology)
  • Review
  • Open Access
15 Citations
5,068 Views
14 Pages

Pathways to Alzheimer’s Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health

  • Alexandru Laslo,
  • Laura Laslo,
  • Eliza-Mihaela Arbănași,
  • Alexandru-Andrei Ujlaki-Nagi and ,
  • Laura Chinezu,
  • Adrian Dumitru Ivănescu,
  • Emil-Marian Arbănași,
  • Roxana Octavia Cărare,
  • Bogdan Andrei Cordoș and
  • Klara Brînzaniuc
  • + 6 authors+ 1 author

One of the hallmarks of Alzheimer’s disease (AD) is the deposition of amyloid-β (Aβ) within the extracellular spaces of the brain as plaques and along the blood vessels in the brain, a condition also known as cerebral amyloid angiopat...

  • Article
  • Open Access
1,267 Views
16 Pages

Enhancement of Cytoskeletal Tension Promotes Amyloid-β Aggregation on the Neuronal Cell Surface

  • Juri Nakayama,
  • Yuna Fujiya,
  • Kiyotaka Tokuraku and
  • Masahiro Kuragano

19 February 2026

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that accounts for the majority of dementia cases. The accumulation of amyloid-β (Aβ) aggregates on neuronal surfaces is a known important event that typifies AD. Alt...

(This article belongs to the Special Issue 30th Anniversary of Molecules—Recent Advances in Chemical Biology)
  • Article
  • Open Access
20 Citations
7,934 Views
11 Pages

Effects of Vitamin B12 Deficiency on Amyloid-β Toxicity in Caenorhabditis elegans

  • Arif Andra,
  • Shoko Tanigawa,
  • Tomohiro Bito,
  • Atsushi Ishihara and ,
  • Fumio Watanabe and
  • Yukinori Yabuta
  • + 1 author+ 0 author

High homocysteine (Hcy) levels, mainly caused by vitamin B12 deficiency, have been reported to induce amyloid-β (Aβ) formation and tau hyperphosphorylation in mouse models of Alzheimer’s disease. However, the relationship between B12 deficiency and A...

(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)
  • Article
  • Open Access
24 Citations
10,762 Views
13 Pages

6 April 2011

The main objective of the presented study was the development of a simple analytical tool for exploring the influence of naturally occurring compounds on the aggregation of amyloid-β peptide (Aβ40) in order to find potential anti-neurodegenerative dr...

(This article belongs to the Special Issue Bioinspired Sensor Systems)
  • Review
  • Open Access
25 Citations
6,669 Views
21 Pages

Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development

  • Anatoly S. Urban,
  • Konstantin V. Pavlov,
  • Anna V. Kamynina,
  • Ivan S. Okhrimenko and ,
  • Alexander S. Arseniev and
  • Eduard V. Bocharov
  • + 1 author+ 0 author

Alzheimer’s disease is the most common type of neurodegenerative disease in the world. Genetic evidence strongly suggests that aberrant generation, aggregation, and/or clearance of neurotoxic amyloid-β peptides (Aβ) triggers the disease. Aβ accumulat...

(This article belongs to the Special Issue Bioactive Peptides and Proteins)
  • Article
  • Open Access
4,554 Views
16 Pages

Novel Monoclonal Antibody Specific toward Amyloid-β Binds to a Unique Epitope within the N-Terminal Region

  • Giavanna Paterno,
  • Brenda D. Moore,
  • Brach M. Bell,
  • Kimberly-Marie M. Gorion and ,
  • Yong Ran,
  • Stefan Prokop,
  • Todd E. Golde and
  • Benoit I. Giasson
  • + 3 authors+ 0 author

9 August 2024

Amyloid-β (Aβ) deposition throughout the neuroaxis is a classical hallmark of several neurodegenerative diseases, most notably Alzheimer’s disease (AD). Aβ peptides of varied length and diverse structural conformations are deposi...

  • Article
  • Open Access
19 Citations
6,525 Views
18 Pages

Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers

  • Ryan Limbocker,
  • Benedetta Mannini,
  • Rodrigo Cataldi,
  • Shianne Chhangur and ,
  • Aidan K. Wright,
  • Ryan P. Kreiser,
  • J. Alex Albright,
  • Sean Chia,
  • Johnny Habchi and
  • Michele Vendruscolo
  • + 11 authors+ 6 authors

Alzheimer’s disease is associated with the aggregation of the amyloid-β peptide (Aβ), resulting in the deposition of amyloid plaques in brain tissue. Recent scrutiny of the mechanisms by which Aβ aggregates induce neuronal dysfun...

(This article belongs to the Special Issue Protein Aggregates Toxicity: New Insights into the Mechanisms)
  • Review
  • Open Access
44 Citations
6,664 Views
31 Pages

Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides

  • Yaliang Huang,
  • Yong Chang,
  • Lin Liu and
  • Jianxiu Wang

15 July 2021

The aberrant aggregation of amyloid-β (Aβ) peptides in the brain has been recognized as the major hallmark of Alzheimer’s disease (AD). Thus, the inhibition and dissociation of Aβ aggregation are believed to be effective therapeutic strategiesforthe...

(This article belongs to the Special Issue Functional Nanomaterials in Biomedicine)
  • Article
  • Open Access
28 Citations
3,664 Views
13 Pages

26 October 2021

Amyloid-β (Aβ) deposition, a hallmark of Alzheimer’s disease, is known to induce free radical production and oxidative stress, leading to neuronal damage. During oxidative stress, several cell types (including astrocytes) can activate the nuclear fac...

(This article belongs to the Special Issue Role of Oxidative Stress and Antioxidants in Pathophysiology: A Commemorative Special Issue in Honour of Professor Mario Umberto Dianzani)
  • Article
  • Open Access
4 Citations
1,395 Views
21 Pages

Novel Small-Molecule Analogues of IU1 Ameliorate Amyloid-β Mediated Toxicity in Alzheimer’s Disease Cell and Worm Models

  • Ajish Ariyath,
  • Fraulein Denise Arigo,
  • Izhar Wallach,
  • W. M. A. D. Binosha Fernando and ,
  • Ralph N. Martins and
  • Prashant Bharadwaj
  • + 1 author+ 0 author

18 February 2026

Dysregulation of the deubiquitinating enzyme Ubiquitin-specific peptidase 14 (USP14) is implicated in several neurodegenerative diseases, and IU1, an allosteric inhibitor, has shown neuroprotective effects by reducing protein aggregate toxicity. This...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
5 Citations
2,980 Views
11 Pages

Elucidating the Unique J-Shaped Protomer Structure of Amyloid-β(1-40) Fibril with Cryo-Electron Microscopy

  • Raymond N. Burton-Smith,
  • Maho Yagi-Utsumi,
  • Saeko Yanaka,
  • Chihong Song and ,
  • Kazuyoshi Murata and
  • Koichi Kato
  • + 1 author+ 0 author

29 January 2025

Although the structural diversity of amyloid-β (Aβ) fibrils plays a critical role in the pathology of Alzheimer’s disease (AD), the mechanisms underlying this diversity remain poorly understood. In this study, we report the discovery...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
2 Citations
2,498 Views
15 Pages

SKGQA, a Peptide Derived from the ANA/BTG3 Protein, Cleaves Amyloid-β with Proteolytic Activity

  • Yusuke Hatakawa,
  • Rina Nakamura,
  • Toshifumi Akizawa,
  • Motomi Konishi and ,
  • Akira Matsuda,
  • Tomoyuki Oe,
  • Motoaki Saito and
  • Fumiaki Ito
  • + 3 authors+ 0 author

Despite the extensive research conducted on Alzheimer’s disease (AD) over the years, no effective drug for AD treatment has been found. Therefore, the development of new drugs for the treatment of AD is of the utmost importance. We recently rep...

(This article belongs to the Special Issue Amyloid-Beta and Alzheimer’s Disease)
  • Review
  • Open Access
166 Views
30 Pages

Natural polyphenols are routinely labeled as inhibitors of amyloid-β (Aβ) aggregation, yet many redirect or remodel selected assembly steps rather than suppressing them. Because Aβ occupies interconverting monomeric, oligomeric, protof...

(This article belongs to the Special Issue Advances in Molecular Biology and Therapeutics: From Natural Products to Pharmaceutical Agents)
  • Article
  • Open Access
36 Citations
5,569 Views
20 Pages

Inhibition of Acetylcholinesterase and Amyloid-β Aggregation by Piceatannol and Analogs: Assessing In Vitro and In Vivo Impact on a Murine Model of Scopolamine-Induced Memory Impairment

  • Yi-Yan Sie,
  • Liang-Chieh Chen,
  • Cai-Jhen Li,
  • Yu-Hsiang Yuan and ,
  • Sheng-Hung Hsiao,
  • Mei-Hsien Lee,
  • Ching-Chiung Wang and
  • Wen-Chi Hou
  • + 3 authors+ 0 author

Currently, no drug is effective in delaying the cognitive impairment of Alzheimer’s disease, which ranks as one of the top 10 causes of death worldwide. Hydroxylated stilbenes are active compounds that exist in fruit and herbal plants. Piceatan...

(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)
  • Review
  • Open Access
84 Citations
9,684 Views
25 Pages

26 February 2021

Amyloid-β (Aβ) accumulations have been identified in the retina for neurodegeneration-associated disorders like Alzheimer’s disease (AD), glaucoma, and age-related macular degeneration (AMD). Elevated retinal Aβ levels were associated with progressiv...

(This article belongs to the Special Issue Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases 2.0)
  • Article
  • Open Access
178 Views
17 Pages

DOPA-Substituted KLVFFA Peptides Potently Inhibit Amyloid-β Aggregation and Mitigate Neurotoxicity

  • Kiyoshi Fukuhara,
  • Kazunori Mori,
  • Yoshio Okiyama,
  • Takashi Takaki and ,
  • Takashi Misawa,
  • Keisuke Tsuchiya,
  • Yosuke Demizu,
  • Motoko Shibanuma and
  • Akiko Ohno
  • + 4 authors+ 0 author

24 October 2026

Alzheimer’s disease (AD) is driven primarily by the self-assembly of amyloid-β (Aβ) peptides, a process stabilized by intermolecular π–π stacking interactions involving Phe19 and Phe20 residues of adjacent Aβ molecule...

(This article belongs to the Special Issue Neurodegenerative Disease: From Molecular Basis to Therapy, 5th Edition)
  • Review
  • Open Access
24 Citations
6,719 Views
16 Pages

Lewy body diseases (LBD) are pathologically defined as the accumulation of Lewy bodies composed of an aggregation of α-synuclein (αSyn). In LBD, not only the sole aggregation of αSyn but also the co-aggregation of amyloidogenic prot...

(This article belongs to the Special Issue The Structure and Function of Synuclein)
  • Article
  • Open Access
17 Citations
6,156 Views
22 Pages

Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells

  • Emma Ristori,
  • Vittoria Cicaloni,
  • Laura Salvini,
  • Laura Tinti and ,
  • Cristina Tinti,
  • Michael Simons,
  • Federico Corti,
  • Sandra Donnini and
  • Marina Ziche
  • + 4 authors+ 0 author

19 November 2020

The amyloid-β precursor protein (APP) is a ubiquitous membrane protein often associated with Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA). Despite its role in the development of the pathogenesis, APP exerts several physio...

(This article belongs to the Special Issue Vascular Signalling)

of 55